Proficiency testing (PT) is pivotal in assessing laboratory qualifications for certification and licensure. PT is expected to typify routine assay performance and determine whether the laboratory is producing clinically useful test results. Conventional schemes use mail-distributed test specimens and are often criticized as measuring the best possible laboratory performance, principally because of special practices associated with processing PT specimens. We used on-site proficiencytests and splitsamples to evaluate the ability of conventional PT schemes to accurately characterize routine laboratory performance.
performing at a substandard level to progress toward the analytical goals as set forth in the PT program evaluation criteria (7, 8) and random (S,) errors in the data collected from the two PT modes ( Table 2 ). The accuracy of routine patient testing for theophylline vs our results obtained by reanalysis of patients' specimens by HPLC is provided in Figure 1 ; the regression-analysis statistics are provided in Table 2 . As noted The accuracy of routine patient testing vs the error in patients' results as predicted by laboratory performance in the PT program is shown in Figure 2 noted that results from the Kodak Ektachem were responsible for all but one event in cell U of the allmethods frame. To illustrate further the method-dependent correlation between accuracy in the analysis of patients' specimens and the accuracy of performance evaluations by PT, we plotted the averages of the reported error vs the predicted error of results.
As shown in Figure 3 , there is good agreement between the errors, suggesting the similarity in behavior of PT and patients' specimens. The exception was the Ektachem, We categorized the inaccuracy of reported patients' results either as being within the error limits predicted by laboratory performance in the PT program or as not being consistent with PT performance. The outcome of the analysis is provided as acceptable performance in PT, that is, the ability of acceptable PT performance to exclude substandard reliability of routine patient testing, was 94%. The efficiency of PT performance evaluations was measured by the percentage of patients' assays correctly predicted to be within (TN) or to exceed (TP) the threshold of allowable error and was determined to be 94%.
DIscussIon
PT through use of announced test events and maildistributed test specimens is often considered an assessment of the best performance that a laboratory can Act of 1967 (CLIA '67), -53% of the laboratories that they surveyed acknowledged atypical handling of PT specimens, principally through replicate analysis and reporting of mean or median values. In the existing regulatory environment where the laboratory's ability to offer service is contingent on successful PT performance, the pressure to achieve acceptable scores is high.
Although the motive and opportunity for special treatment of PT specimens is obvious, the benefit to the laboratory and the impact on program assessment of laboratory performance is not. Gambino et al. (12) The characterization of method-dependent systematic error poses a challenge to the PT provider. Ideally, an accuracy-based target value is used to judge method and laboratory performance (14) . This approach to performance evaluation requires test specimens that mimic the behavior of authentic patients' specimens in the Wherever there is suspicion of a matrix-related effect on assay performance, the source of interference should be characterized and either shown to be atypical of authentic patients' specimens or stated as a limitation of the method. Once the interference is characterized, the use of the mean concentration of the peer-group results as the target value is an option for performance evaluation, provided that the method has been proven to be accurate in the analysis of patient specimens. Judging from our findings, the Ektachem method for theophylline is an instance where, on average, patients' results are biased high but to a lesser extent than was anticipated from the systematic error of PT results. The PT program was not sensitive to the error in patient testing because the method mean was used as the target value for performance evaluation.
We conclude that the most significant challenge to the PT program in achieving its goal of accurately characterizing the quality of routine patient testing is the validation of the test specimens. Validation and to provide an effective means of assessing whether the laboratory is producing clinically useful test results.
